ALIROCUMAB IN HIGH-RISK PATIENTS WITH BASELINE LDL-C >= 160 MG/DL: FINDINGS FROM THE COMPASSIONATE USE PROGRAM-MedSci.cn

ALIROCUMAB IN HIGH-RISK PATIENTS WITH BASELINE LDL-C >= 160 MG/DL: FINDINGS FROM THE COMPASSIONATE USE PROGRAM

Glueck, CJ; Brown, A; Goldberg, A; McKenney, J; Kantaros, L; Stewart, J; Elassal, J; Koren, A